Scientists in Cyprus have found 25 cases of a strain of the coronavirus that they say combines elements of the delta and omicron variants, dubbing it “deltacron,” with a high proportion of the variant found in patients hospitalized for Covid-19, a professor involved in the identification of the new strain said Saturday.
one thing for sure..gloves sales much2 higher than pre covid era.. means profit masih kekal banyak2 ler.. with number of infection in this region olso skyrocket now.. sooner or later.. ppl will get back to glove counters.. monday would be the last day for u guys. I believe la.. hehe.
WASHINGTON - The United States Centres for Disease Control and Prevention (CDC) is working with Singapore's Ministry of Health regarding the country's Covid-19 testing data, the US agency told Bloomberg News on Thursday (Jan 6).
The CDC will also update its Travel Health Notice for Singapore accordingly.
The move comes days after the CDC earlier this week reclassified its Covid-19 advisory for Singapore and said the situation in the country was "unknown".
The CDC's designation surprised officials in Singapore, which maintains far stricter testing and social distancing measures than the US, and its Ministry of Health posts detailed virus statistics in English online every day.
In response, Singapore said it would share its Covid-19 statistics with the CDC and the local US embassy.
"Just to be clear, we know our situation very well," Health Minister Ong Ye Kung told reporters on Wednesday.
This is happen when us not happy with you and find an excuse to blame and kacau you. Just like us don't happy with your country, find an excuse of forced labour to your country company etc gloves companies over forced labour claim.
That put Singapore in the company of Afghanistan, North Korea and Syria under a category of destinations which Americans are told to avoid because of high infections.
DUBAI/WASHINGTON (Reuters) -- The United Arab Emirates has informed the United States that it will suspend discussions to acquire F-35 fighter jets, a UAE official said on Tuesday, part of a $23 billion deal that also includes drones and other advanced munitions.
The sale of 50 F-35 warplanes made by Lockheed Martin to the UAE had slowed amid concerns in Washington over Abu Dhabi's relationship with China, including use of Huawei 5G technology in the country.
"Technical requirements, sovereign operational restrictions, and cost/benefit analysis led to the re-assessment," the UAE official said in a statement to Reuters that confirmed a report in the Wall Street Journal.
Nimble all you can and waiting to cash out pre post CNY rally or GE sentiment when funds flowing into Bursa again. Set TP 15-20% or additional 10% max returns.
the edge article sounds like the author thinks soon there will be world peace, most people healthy without sickness, glove usage will drop drastically. Althou i don't wish for it to happen but, i would say catastrophes will keep on coming, if we continue our never ending progress of destruction to earth, and more likely we won't stop soon... so, whatever nonsense we chasing after, chaos is quite inevitable.
Supermax can't export to US market since October and their US market share already taken over by other top 3 glove companies and new record high hospitalizations in US has caused very high usage and demands of gloves in US healthcare systems
Sooner or later... reality kicks in... Covid is NOT going to away so soon. I hate wearing Mask, check-in on MySejahtera and social distancing empty seats BS in MRT and these BS will be with us for a few years down the line. Gloves will always be on high demand and with more New variances, it will be in more demand. Should have bought TG and SM last month... WTF.
UK faces legal action for approving firm accused of using forced labour as PPE supplier High court to review government’s decision to include subsidiary of Malaysia’s Supermax in £6bn ‘framework’ deal for buying gloves
The UK government is facing legal action over its decision to keep using a Malaysian company accused of using forced labour as a supplier of personal protective equipment (PPE) to the NHS.
Lawyers at the London-based law firm Wilson Solicitors have filed for a judicial review of the government’s decision to name the UK subsidiary of the Malaysian company Supermax as one of the approved suppliers in a new £6bn contract for disposable gloves for NHS workers.
Supermax has faced persistent allegations of the use of forced labour involving its migrant workforce at factories in Malaysia since 2019. In October 2021, the US banned imports from Supermax after an investigation found “ample evidence” of forced labour. Canada halted federal imports in November 2021, also due to concerns over labour abuses.
In 2019 Supermax workers claimed they had to work 30 days in a row without a day off and had paid high fees in their home countries to get the jobs. The company denied the allegations.
After the US ban, the UK government launched its own investigation into the allegations of modern slavery and forced labour concerning Supermax. But in December 2021 Supermax was named as one of the approved suppliers able to pitch for contracts under NHS Supply Chain’s new “framework agreement” for the purchase of surgical gloves.
The United States is poised to surpass its record for covid-19 hospitalizations as soon as Tuesday, with no end in sight to skyrocketing case loads, falling staff levels and the struggles of a medical system trying to provide care amid an unprecedented surge of the coronavirus.
Monday’s total of 141,385 people in U.S. hospitals with covid-19 fell just short of the record of 142,273 set on Jan. 14, 2021, during the previous peak of the pandemic in this country.
But the highly transmissible omicron variant threatens to obliterate that benchmark. If models of omicron’s spread prove accurate — even the researchers who produce them admit forecasts are difficult during a pandemic — current numbers may seem small in just a few weeks. Disease modelers are predicting total hospitalizations in the 275,000 to 300,000 range when the peak is reached, probably later this month.
RM1.44, the panic alarm been triggered and reaching a new low soon. Be wary as the trap moves on. This counter cocked-up. Funds and Supermax do not want to buy.
Pfizer CEO Albert Bourla on Monday said two doses of the company’s vaccine may not provide strong protection against infection from the omicron Covid variant, and the original shots have also lost some of their efficacy at preventing hospitalization.
Bourla, in an interview at J.P. Morgan’s healthcare conference, emphasized the importance of a third shot to boost people’s protection against omicron.
“The two doses, they’re not enough for omicron,” Bourla said. “The third dose of the current vaccine is providing quite good protection against deaths, and decent protection against hospitalizations.”
Bourla said omicron is a more difficult target than previous variants. Omicron, which has dozens of mutations, can evade some of the protection provided by Pfizer’s original two shots.
Not going to rub salts on your wound but I do not understand how you define the share price as supercheap. Maybe you are considering P/E ratio, NTA, cash on hand etc., who knows? Any bad news later, this counter could be a dead duck. After all, it is already deteriorating.
What I see is no fund wants it so far. Someone experienced can please enlighten me. Thank you.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Ryan83
1,835 posts
Posted by Ryan83 > 2022-01-09 12:59 | Report Abuse
Scientists in Cyprus have found 25 cases of a strain of the coronavirus that they say combines elements of the delta and omicron variants, dubbing it “deltacron,” with a high proportion of the variant found in patients hospitalized for Covid-19, a professor involved in the identification of the new strain said Saturday.